Andrew M. Eisenberg

Andrew Eisenberg advises clients on a wide range of federal income tax issues related to corporate mergers and acquisitions. His practice includes taxable and tax-free stock and asset acquisitions and dispositions, post-acquisition restructurings, incorporation transactions, liquidating and non-liquidating distributions, application of the consolidated return regulations, and general tax consequences of transactions between shareholders and corporations. He has extensive experience practicing before the U.S. Treasury Department and the Internal Revenue Service, including representing clients in the private letter ruling process.

Andrew advised Pfizer in its post-acquisition integration of Pharmacia, Celgene in its post-acquisition integration of Pharmion, Ospraie Management in its $2.1 billion acquisition of ConAgra Foods' commodities trading unit, and Huntington Bank in its acquisition of Franklin Financial's mortgage loan portfolio. [1]